NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE,PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, INWHOLE OR IN ...
Announced the U.S. FDA has accepted our Biologics License Application (BLA) seeking full approval of deramiocel for the treatment of Duchenne ...
Plasmalex, a leader in advanced coating solutions, proudly introduces PlasmaGuard X, the newest innovation in its PlasmaGuard® platform of high-performance barrier coatings. It is the result of years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback